ATM.md
... ...
@@ -10,13 +10,13 @@ nocite: |
10 10
## Overview
11 11
12 12
Mutations in this gene were first described in MZL by Braggio et al.[@braggioGenomicAnalysisMarginal2012] then in MCL by Bea et al.[@beaLandscapeSomaticMutations2013] ATM mutations were later described in DLBCL by Reddy et al.[@reddyGeneticFunctionalDrivers2017]
13
-The role of ATM in DLBCL remains unclear.
13
+Although there is [experimental data](#experimental-evidence) supporting its relevance in MCL, the role of ATM in DLBCL remains unclear.
14 14
[Selective pressure analysis](#mutation-pattern-and-selective-pressure-estimates) did not identify this gene as significantly enriched for either missense or truncating mutations, indicating that many of these mutations may represent passengers.
15 15
16 16
17 17
## Experimental Evidence
18 18
19
-Driver mutations affecting this gene in DLBCL have been experimentally demonstrated to cause a reduction or loss of function (LOF).[@camachoATMGeneInactivation2002]
19
+Driver mutations affecting this gene in MCL have been experimentally demonstrated to cause a reduction or loss of function (LOF).[@camachoATMGeneInactivation2002]
20 20
21 21
## Relevance tier by entity
22 22